1. Home
  2. BNTX vs PHG Comparison

BNTX vs PHG Comparison

Compare BNTX & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

N/A

Current Price

$85.42

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Logo Koninklijke Philips N.V. NY Registry Shares

PHG

Koninklijke Philips N.V. NY Registry Shares

N/A

Current Price

$30.27

Market Cap

23.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNTX
PHG
Founded
2008
1891
Country
Germany
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
23.7B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
BNTX
PHG
Price
$85.42
$30.27
Analyst Decision
Buy
Hold
Analyst Count
21
5
Target Price
★ $113.11
$33.58
AVG Volume (30 Days)
975.2K
★ 1.5M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
★ 2.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.03
Revenue Next Year
$0.50
$4.96
P/E Ratio
★ N/A
$28.46
Revenue Growth
N/A
N/A
52 Week Low
$79.81
$23.62
52 Week High
$124.00
$33.44

Technical Indicators

Market Signals
Indicator
BNTX
PHG
Relative Strength Index (RSI) 40.36 70.29
Support Level $79.81 $25.53
Resistance Level $93.48 $31.14
Average True Range (ATR) 2.52 0.55
MACD 0.09 0.16
Stochastic Oscillator 18.05 81.62

Price Performance

Historical Comparison
BNTX
PHG

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Share on Social Networks: